Aticaprant Aticaprant
GMP ISO TDS 22 Inquiries
1174130-61-0
Pharmaceutical Grade
99.75%
c
Million
1g 10g 100g 1kg/bag 25kg/Cardboard Drum
2025-03-08
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide
Other Name:(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide;LY2456302;LY 2456302;CERC501;CERC 501;CS-2732;CERC-501(LY-2456302,Aticaprant);Benzamide, 4-[4-[[(2S)-2-(3,5-dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluoro-;4-[4-[[(2S)-2-(3,5-Dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluorobenzamide;Aticaprant (CERC-501);CERC 501,inhibit,LY2456302,Opioid Receptor,Aticaprant,Inhibitor,CERC501,LY 2456302
CAS No.:1174130-61-0
Molecular Formula:C26H27FN2O2
InChIKeys:ZHPMYDSXGRRERG-DEOSSOPVSA-N
Molecular Weight:418.5
Exact Mass:418.50
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.201±0.06 g/cm3(Predicted)
Boiling Point:519.2±50.0 °C(Predicted)
PKA:15.61±0.50(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Location:
Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China
-
Payment Terms:
L/C,100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2012
-
Certifications:
business license
-
-
Inquiry History22 Inquiries
Country Product Purchase Quantity Date Posted
Poland
LY2456302 Aticaprant CAS 1174130-61-0
2 G Feb 22, 2026
United States
Aticaprant Cas No. 1174130-61-0
1 G Feb 13, 2026
United Kingdom
Aticaprant LY-2456302 LY2456302 CAS 1174130-61-0
1 G Jan 14, 2026
United States
CERC-501(LY-2456302,Aticaprant)
1.0 G Jun 16, 2026
United States
Aticaprant
1 MT Jan 28, 2026
United States
Aticaprant
1 MT Jan 4, 2026
Slovakia
Aticaprant
1 G Dec 26, 2025
United States
Aticaprant
1 G Dec 26, 2025
Poland
aticaprant
1 G Mar 30, 2026
China
LY-2456302,Aticaprant
100 MG Mar 6, 2026
Canada
Aticaprant
1 G Mar 5, 2026
China
Aticaprant
1 G Mar 4, 2026
Brazil
Aticaprant
1 G Feb 25, 2026
Poland
Aticaprant
10 G Feb 22, 2026
United States
4-[4-[[(2S)-2-(3,5-Dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluorobenzamide
1 G Feb 19, 2026
France
Aticaprant
1 G Aug 18, 2026
United States
Aticaprant
50 G May 12, 2026
Switzerland
Aticaprant
1 G Apr 10, 2026
United States
Aticaprant
1 G Mar 4, 2026
United States
Aticaprant
1 G Feb 23, 2026 Post an enquiry for this product
